Listed equity
Caplin Point Laboratories
कैपलिन पॉइंट · કેપલિન લેબ્સ
₹2505.00▼₹11.85(-0.47%)
EOD close · 3 Jul 2026
mid rallyaccumulation +35
Trend and delivery agree: the price is rising and high-conviction buyers are taking delivery. Strength with substance.
52W low ₹1502.4552W high ₹2680.00
Now at 85% of its 52-week range
Long-term returns
1Y
+26.6%
3Y
+213.8%
5Y
+272.9%
10Y
+1081.8%
Phase indicator
mid rally-6.5% from 52w high
Above 50- and 200-day MAs with +61.7% over 3 months — established uptrend.
1M
+28.4%
3M
+61.7%
1Y
+26.6%
Delivery conviction
accumulationscore +35
Delivery vs 20-day avg1.33x
Lifetime story
Caplin Point Laboratories is up 1391566.7% from its lifetime low of ₹0.18 on 27 Feb 2002. ₹10,000 invested then would be worth ₹13,91,66,667 today (48.0% CAGR over 24.3 years). Lifetime high of ₹2680.00 was set on 1 Jul 2026 (currently -6.5% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
1% premium to industry(Industry P/E 49.5)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 50.03 | 30.05 |
| P/Bsubs material | 9.40 | 5.38 |
| Price / Cash flowsubs material | 46.92 | 26.99 |
| Dividend yield | 0.16% | 0.16% |
| Book value / sharesubs material | 269.76 ₹ | 471.83 ₹ |
| EPS (TTM)subs material | 50.68 ₹ | 84.36 ₹ |
Market cap
₹19.3K Cr
52W high
₹2680.00
1 Jul 2026
52W low
₹1502.45
30 Mar 2026
Returns ladder
1W
+1.1%
1M
+28.4%
3M
+61.7%
6M
+37.0%
YTD
+37.7%
1Y
+26.6%
3Y
+213.8%
5Y
+272.9%
10Y
+1081.8%
Since listing
+10000.0%